Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Control of nucleolar stress and translational reprogramming by lncRNAs.

Verheyden Y, Goedert L, Leucci E.

Cell Stress. 2018 Dec 5;3(1):19-26. doi: 10.15698/cst2019.01.172. Review.

2.

SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation.

Vendramin R, Verheyden Y, Ishikawa H, Goedert L, Nicolas E, Saraf K, Armaos A, Delli Ponti R, Izumikawa K, Mestdagh P, Lafontaine DLJ, Tartaglia GG, Takahashi N, Marine JC, Leucci E.

Nat Struct Mol Biol. 2018 Nov;25(11):1035-1046. doi: 10.1038/s41594-018-0143-4. Epub 2018 Oct 29.

3.

Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis.

Goedert L, Plaça JR, Fuziwara CS, Machado MCR, Plaça DR, Almeida PP, Sanches TP, Santos JFD, Corveloni AC, Pereira IEG, de Castro MM, Kimura ET, Silva WA Jr, Espreafico EM.

Sci Rep. 2017 May 10;7(1):1662. doi: 10.1038/s41598-017-01957-0.

4.

MYO5A Gene Is a Target of MITF in Melanocytes.

Alves CP, Yokoyama S, Goedert L, Pontes CLS, Sousa JF, Fisher DE, Espreafico EM.

J Invest Dermatol. 2017 Apr;137(4):985-989. doi: 10.1016/j.jid.2016.11.026. Epub 2016 Dec 6. No abstract available.

5.

RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.

Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva WA Jr, Davies MA, Espreafico EM.

Oncotarget. 2016 Jun 14;7(24):36711-36718. doi: 10.18632/oncotarget.9164.

6.

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.

Hu-Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, Pinheiro EM, Koya RC, Graeber TG, Comin-Anduix B, Ribas A.

Sci Transl Med. 2015 Mar 18;7(279):279ra41. doi: 10.1126/scitranslmed.aaa4691.

Supplemental Content

Loading ...
Support Center